Biostar Makes a Deal for New Topical Skin Disease Treatment

Did you know?

ChinaBio^® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…

More white papers:

>>China Partnering 2012: Driving Future Innovation

>>China Life Science 2012: From Local to Global

Free Content

Week in Review

In My Opinion

Free Articles

Education Center

Interfax-BW Releases

Subscriber Content

Biostar Makes a Deal for New Topical Skin Disease Treatment

publication date: Jun 13, 2012

Biostar Pharmaceuticals and The Fourth Military Medical University (FMMU) signed a Letter of Intent regarding Viacom Pine II Cream, a topical treatment for bacterial and fungal infections, dermatitis and eczema. In return for underwriting the cost of Phase I through III clinical trials for SFDA approval of the product, Biostar will gain the right to sell Viacom in China. FMMU will retain the ability to distribute it directly to military personnel. More details....

Stock Symbol: (NSDQ GM: BSPM)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Click here to join.